Matrix metalloproteinases and their inhibitors in kidney scarring: Culprits or innocents

Journal of Health Science

Volumn 55, Issue 4, 2009, Pages 473-483

  Ahmed, Aimun Kamal Hussein ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Chronic kidney disease; Kidney fibrosis; Kidney scarring; Matrix metalloproteinases; Tissue inhibitors of matrix metalloproteinases

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; COLLAGEN TYPE 5; COLLAGENASE; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN; GELATINASE; LAMININ; MATRILYSIN; MATRIX METALLOPROTEINASE; PLATELET DERIVED GROWTH FACTOR; PROTEOCHONDROITIN SULFATE; PROTEOHEPARAN SULFATE; RETINOID; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA1;

BOWMAN CAPSULE; CHRONIC KIDNEY DISEASE; ENZYME ACTIVATION; ENZYME REGULATION; EXTRACELLULAR MATRIX; HENLE LOOP; HUMAN; KIDNEY FAILURE; KIDNEY SCAR; MESANGIUM CELL; NONHUMAN; REVIEW; STREPTOZOCIN DIABETES;

EID: 68949136654     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.55.473     Document Type: Review

References (75)

1. Schnaper, H. W., Hayashida, T., Hubchak, S. C., Poncelet, A. C. (2003) TGF-beta signal transduction and mesangial cell fibrogenesis. Am. J. Physiol. Renal. Physiol., 284, F243-F252. (Pubitemid 36114687)
2. Liu, Y. (2006) Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int., 69, 213-217. (Pubitemid 43323069)
3. Lenz, O., Elliot, S. J. and Stetler-Stevenson, W. G. (2000) Matrix metalloproteinases in renal development and disease. J. Am. Soc. Nephrol., 11, 574-581. (Pubitemid 30115088)
4. Arthur, M. J. (1998) Fibrosis and altered matrix degradation. Digestion, 59, 376-380.
5. McDougall, S., et al. (2006) Fibroblast migration and collagen deposition during dermal wound healing: mathematical modelling and clinical implications. Philos. Transact. A, Math. Phys. Eng. Sci., 364, 1385-1405. (Pubitemid 43893617)
6. Jones, C. (1996) Matrix regulation in renal disease. Nephrology (Carlton), 2, 13-23.
7. Berkholtz, C. B., et al. (2006) Distribution of extracellular matrix proteins type I collagen, type IV collagen, fibronectin, and laminin in mouse folliculogenesis. Histochem. Cell Biol., 126, pp. 583-592.
8. Miyazaki, M., et al. (2003) Regulation of renal extracellular matrix metabolism. Contrib. Nephrol., 139, 141-155.
9. Mulloy, B. and Rider, C. C. (2006) Cytokines and proteoglycans: an introductory overview. Biochem. Soc. Trans., 34(Pt3), 409-413.
10. Bosman, F. T. and Stamenkovic, I. (2003) Functional structure and composition of the extracellular matrix. J. Pathol., 200, 423-428.
11. Brown, B., et al. (2006) The basement membrane component of biologic scaffolds derived from extra-cellular matrix. Tissue Eng., 12, 519-526. (Pubitemid 43673457)
12. Mott, J. D. and Werb, Z. (2004) Regulation ofmatrix biology by matrix metalloproteinases. Curr. Opin. Cell Biol., 16, 558-564.
13. Egeblad, M. and Werb, Z. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer, 2, 161-174.
14. Overall, C. M. (2001) Matrix metalloproteinase substrate binding domains, modules and exosites. Overview and experimental strategies. Methods Mol. Biol., 151, 79-120.
15. Sternlicht, M. D. and Werb, Z. (2001) How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol., 17, 463-516. (Pubitemid 33096184)
16. Knauper, V., et al. (1997) The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J. Biol. Chem., 272, 7608-7616. (Pubitemid 27137308)
17. Knauper, V., et al. (1997) Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). Eur. J. Biochem., 248, 369-373. (Pubitemid 27387479)
18. Kojima, S., et al. (2000) Membrane-type 6 matrix metalloproteinase (MT6-MMP, MMP-25) is the second glycosyl-phosphatidyl inositol (GPI)-anchored MMP. FEBS Lett., 480, 142-146. (Pubitemid 30682491)
19. Catania, J. M., Chen, G. and Parrish, A. R. (2007) Role of matrix metalloproteinases in renal pathophysiologies. Am. J. Physiol. Renal. Physiol., 292, F905-F911. (Pubitemid 46393417)
20. Murphy, G., et al. (1999)Mechanisms for pro matrix metalloproteinase activation. APMIS, 107, 38-44. (Pubitemid 29133521)
21. Morrison, C. J. and Overall, C. M. (2006) TIMPindependence of MMP-2 activation by MT2-MMP is determined by contributions of both the MT2-MMP catalyic and hemopexin C domains. J. Biol. Chem., 281, pp. 26528-26539.
22. Kwak, H. J., et al. (2006) Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells. Mol. Cancer Res., 4, 209-220.
23. Baricos, W. H., et al. (1995) ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int., 47, 1039-1047.
24. Chegini, N. (1997) The role of growth factors in peritoneal healing: transforming growth factor beta (TGF-beta). Eur. J. Surg. Suppl., (577), 17-23. (Pubitemid 27115966)
25. Naveau, A., et al. (2006) Phenotypic study of human gingival fibroblasts labeled with superparamagnetic anionic nanoparticles. J. Periodontol., 77, 238-247. (Pubitemid 44725077)
26. Seeland, U., et al. (2002) Myocardial fibrosis in transforming growth factor-beta(1) (TGF-beta(1)) transgenic mice is associated with inhibition of interstitial collagenase. Eur. J. Clin. Invest., 32, 295-303. (Pubitemid 36228387)
27. Kitamura, M., et al. (1995) Transfer of a mutated gene encoding active transforming growth factorbeta 1 suppresses mitogenesis and IL-1 response in the glomerulus. Kidney Int., 48, 1747-1757.
28. Baker, A. H., Edwards, D. R. and Murphy, G. (2002) Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell Sci., 115(Pt19), 3719-3727. (Pubitemid 35203598)
29. Gomis-Ruth, F. X., et al. (1997) Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature, 389, 77-81.
30. Yu, W. H., et al. (2000) TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J. Biol. Chem., 275, 31226-31232.
31. Orellana, S. A. and Avner, E. D. (1998) Cell and molecular biology of kidney development. Semin. Nephrol., 18, 233-243. (Pubitemid 28224251)
32. Ota, K., et al. (1998) Cloning of murine membrane-type- 1-matrix metalloproteinase (MT-1-MMP) and its metanephric developmental regulation with respect to MMP-2 and its inhibitor. Kidney Int., 54, 131-142. (Pubitemid 28288027)
33. Barasch, J., et al. (1999) Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros. J. Clin. Invest., 103, 1299-1307. (Pubitemid 29218300)
34. Lelongt, B., et al. (1997) Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro. J. Cell Biol., 136, 1363-1373. (Pubitemid 27421921)
35. Sakurai, H. and Nigam, S. K. (1997) Transforming growth factor-beta selectively inhibits branching morphogenesis but not tubulogenesis. Am. J. Physiol., 272(1Pt2), F139-F146. (Pubitemid 27382290)
36. Johnson, T. S., et al. (2002) Matrix metalloproteinases and their inhibitions in experimental renal scarring. Exp. Nephrol., 10, 182-195.
37. Yang, J., et al. (2002) Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. J. Clin. Invest., 110, 1525-1538. (Pubitemid 35396923)
38. Singhal, P. C., Sagar, S. and Garg, P. (1996) Simulated glomerular pressure modulates mesangial cell 72 kDa metalloproteinase activity. Connect. Tissue Res., 33, 257-263. (Pubitemid 3021575)
39. Sagar, S., et al. (1994) Morphine modulates 72-kDa matrix metalloproteinase. Am. J. Physiol., 267(4Pt2), F654-F659. (Pubitemid 24332474)
40. Reckelhoff, J. F. and Baylis, C. (1993) Glomerular metalloprotease activity in the aging rat kidney: inverse correlation with injury. J. Am. Soc. Nephrol., 3, 1835-1838.
41. Gonzalez-Avila, G., et al. (1998) Changes in matrix metalloproteinases during the evolution of interstitial renal fibrosis in a rat experimentalmodel. Pathobiology, 66, 196-204. (Pubitemid 28404331)
42. Schafer, L., et al. (1995) Role of proteinases in renal hypertrophy and matrix accumulation. Nephrol. Dial. Transplant., 10, 801-807.
43. Nazneen, A., et al. (2002) Possible role of Ets-1 and MMP-1 in matrix remodeling in experimental cisplatin nephropathy. Med. Electron. Microsc., 35, 242-247. (Pubitemid 36205684)
44. Marti, H. P. (2000) Role of matrix metalloproteinases in the progression of renal lesions. Presse Med., 29, 811-817. (Pubitemid 30230286)
45. Salo, T., et al. (1991) Transforming growth factorbeta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. J. Biol. Chem., 266, 11436-11441. (Pubitemid 21906969)
46. Martin, J., et al. (1994) Identification and independent regulation of human mesangial cell metalloproteinases. Kidney Int., 46, 877-885. (Pubitemid 24272048)
47. Jain, S., Bicknell, G. R. and Nicholson, M. L. (2000) Molecular changes in extracellular matrix turnover after renal ischaemia-reperfusion injury. Br. J. Surg., 87, 1188-1192. (Pubitemid 30695464)
48. Dong, F. Q., et al. (2004) [Expression of matrix metalloproteinase-2 and-9 in kidney of diabetic rats]. Zhejiang Da Xue Xue Bao Yi Xue Ban, 33, 245-249.
49. Uchio, K., et al. (2000) Decreased matrix metalloproteinase activity in the kidneys of hereditary nephrotic mice (ICGN strain). Nephron, 86, 145-151. (Pubitemid 30763544)
50. Koide, H., et al. (1997) Effect of unilateral nephrectomy on gene expression of metalloproteinases and their inhibitors. Nephron, 75, 479-483. (Pubitemid 27156744)
51. Schaefer, L., et al. (1997) Differential regulation of glomerular gelatinase B (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in obese Zucker rats. Diabetologia, 40, 1035-1043. (Pubitemid 27381966)
52. McMillan, J. I., et al. (1996) Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J. Clin. Invest., 97, 1094-1101.
53. Chromek, M., et al. (2003) Matrix metalloproteinase- 9 and tissue inhibitor of metalloproteinases- 1 in acute pyelonephritis and renal scarring. Pediatr. Res., 53, 698-705. (Pubitemid 36406743)
54. Eddy, A. A. (1996) Molecular insights into renal interstitial fibrosis. J. Am. Soc. Nephrol., 7, 2495-2508. (Pubitemid 27469555)
55. Eddy, A. A. (1996) Interstitial inflammation and fibrosis in rats with diet-induced hypercholesterolemia. Kidney Int., 50, 1139-1149. (Pubitemid 26342803)
56. Ishidoya, S., et al. (1996) Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int., 49, 1110-1119. (Pubitemid 26122714)
57. Sharma, A. K., et al. (1995) Altered expression of matrix metalloproteinase-2, TIMP, and TIMP-2 in obstructive nephropathy. J. Lab. Clin. Med., 125, 754-761.
58. Tang,W.W., et al. (1994) Extracellular matrix accumulation in immune-mediated tubulointerstitial injury. Kidney Int., 45, 1077-1084. (Pubitemid 24234725)
59. Nakamura, T., et al. (1995) Effect of a specific endothelin A receptor antagonist on murine lupus nephritis. Kidney Int., 47, 481-489.
60. Schaefer, L., et al. (1996) Tubular gelatinase A (MMP-2) and its tissue inhibitors in polycystic kidney disease in the Han: SPRD rat. Kidney Int., 49, 75-81. (Pubitemid 26024229)
61. Nakamura, T., et al. (2000) Elevation of serum levels of metalloproteinase-1, tissue inhibitor of metalloproteinase-1 and type IV collagen, and plasma levels of metalloproteinase-9 in polycystic kidney disease. Am. J. Nephrol., 20, 32-36. (Pubitemid 30047867)
62. Duymelinck, C., et al. (1998) Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathy. Kidney Int., 54, 804-818. (Pubitemid 28397398)
63. Eddy, A. A., et al. (2000) Interstitial fibrosis in mice with overload proteinuria: deficiency of TIMP-1 is not protective. Kidney Int., 58, 618-628.
64. Ahmed, A. K., et al. (2007) Localization of matrix metalloproteinases and their inhibitors in experimental progressive kidney scarring. Kidney Int., 71, 755-763.
65. Kallakury, B. V., et al. (2001) Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin. Cancer Res., 7, 3113-3119. (Pubitemid 32963832)
66. Miyata, Y., et al. (2004) Expression of metalloproteinase- 2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival. Urology, 63, 602-608.
67. Suzuki, D., et al. (1997) In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1 and type IV collagen in diabetic nephropathy. Kidney Int., 52, 111-119. (Pubitemid 27321821)
68. Del Prete, D., et al. (1997) Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM. Diabetologia, 40, 1449-1454. (Pubitemid 28004939)
69. Wang, J., et al. (2002) Expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in IgA nephropathy. Zhonghua Nei Ke Za Zhi, 41, 75-78.
70. Norman, J. T., et al. (1995) Matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases expression by tubular epithelia and interstitial fibroblasts in the normal kidney and in fibrosis. Exp. Nephrol., 3, 88-89.
71. Sanders, J. S., et al. (2004) Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis. Nephrol. Dial. Transplant., 19, 1412-1419. (Pubitemid 38786732)
72. Urushihara, M., et al. (2002) Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis. Nephrol. Dial. Transplant., 17, 1189-1196. (Pubitemid 34812062)
73. Rodrigo, E., et al. (2000) Changes in serum concentrations of matrix metalloproteinases in kidney transplantation. Transplant. Proc., 32, 517-518. (Pubitemid 30254381)
74. Rodrigo, E., et al. (2000) Circulating levels of matrix metalloproteinases MMP-3 and MMP-2 in renal transplant recipients with chronic transplant nephropathy. Nephrol. Dial. Transplant., 15, 2041-2045.
75. Carome, M. A., et al. (1993) Human glomeruli express TIMP-1 mRNA and TIMP-2 protein and mRNA. Am. J. Physiol., 264(6Pt2), F923-F929.